This case highlights the formidable therapeutic challenges of FIP1L1-PDGFRA T674I-positive MPN with eosinophilia with concurrent PTPN11 (p.E76D) mutation. This evidence concerns the gene FIP1L1 and myeloproliferative neoplasm.